ProstaLund
0,988 SEK +2,07%Vær den første som følger denne virksomhed
ProstaLund operates in medical technology. Today, specialisation is mainly in the area of treatment of benign prostate enlargement (BPH). Through the company CoreTherm, heat treatment of benign prostate enlargement is offered, without the need for surgical operation. The vision is to offer both faster and more efficient solutions against traditional forms of infestation. The company was founded in 1991 and is operating globally, based in Lund.
Omsætning
22,21 mio.
EBIT %
-75,87 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
PLUN
Daglig lav / høj pris
0,926 / 0,988
SEK
Markedsværdi
75,67 mio. SEK
Aktieomsætning
26,53 t SEK
Volumen
28 t
Finanskalender
Delårsrapport
16.05.2024
Generalforsamling
30.05.2024
Delårsrapport
19.08.2024
Delårsrapport
07.11.2024
Årsrapport
20.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Mats Alyhr | 20,5 % | 20,5 % |
BFCM P/C BFCM Sweden Retail LT | 8,8 % | 8,8 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Two new studies with ProstaLund´s Schelin Catheter® presented at EAU24 in Paris
Schelin Catheter® - new study confirms efficiency and ease of use
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools